Liver resection is essential part of colorectal cancer liver metastases (CLM) treatment. Mean 5-year overall survival after resection achieves 30-45%. There are many factors influencing long-term outcomes, and among them the inflammatory response to tumor plays an important role. the aim of the study was evaluation of outcomes and treatment safety of patients with metastatic colorectal cancer to the liver with estimation of prognostic factors. Material and methods. 130 consecutive patients (70 men and 60 women) operated in MSC Institute and Cancer Center in Gliwice from 2001 to 2009 due to colorectal liver metastases were analysed. Age of the patients ranged from 33 to 82 years (median 60 years). 96 (74%) patients underwent potentially radical resection, and in remaining 34 (26%) was performed radiofrequency ablation (RFA) alone or combined with the resection. In the resection group 37 right hepatectomies, 11 left hepatectomies, 28 segmentectomies and 20 metastasectomies were performed. Disease-free survival (DFS) and overall survival (OS) were statistically analysed using the Kaplan-Meier method. Factors determining DFS and OS were analysed using Cox regression model. Results. In the resection group the 3-and 5-years OS was 64,5% and 46,6% respectively, and the 3-and 5-years DFS was 32% and 30,5% respectively. In the RFA group the 3-and 5-years OS was 33% and 9,5%. Statistically significant prognostic factors in the resection group in uni-and multivariate analysis were: grade and nodal involvement of the primary tumor, diameter of metastatic focus, positive and narrow (<1 mm) resection margins, preoperative fibrinogen level, preoperative neutrophil to lymphocyte ratio and leukocyte amount of the peripheral blood. The perioperative mortality rate was 3%. Conclusions. Liver resection due to colorectal liver metastases is a safe and effective method resulting in high survival rates. We confirmed some generally accepted prognostic factors influencing longterm outcomes and shown the impact of inflammatory response. We also confirmed the hypothesis that preoperative plasma fibrinogen level influences outcomes after liver resection due to CLM. key words: colorectal cancer liver metastases, liver resection, neutrophil to lymphocyte ratio, fibrinogen
At present, resection of the liver is an essential part of efficacious treatment of metastases of colorectal cancer (CRC) into this organ. In order to obtain optimum treatment results, surgical treatment is combined with chemotherapy, in various sequences, depending on the disease stage. After resection surgery, average overall 5-year survival rate is 30-45%. In non-radical resections, the rate falls to 7%. Patients with non-resectable tumours do not survive 5 years. Average symptom-free survival time is 11.6-17 months (1) . At various centres, authors analysing their own material try to determine unfavourable prognostic factors (2-6). These may be classified as related to the stage of the primary tumour and metastatic lesions (taking into account clinical as well as histopathological, biochemical, and genetic findings).
Although certain risk factors, such as primary lymph node involvement, the number and size of metastatic lesions, or positive resec-tion margins, are widely accepted, many other factors remain controversial. First of all, these include CEA concentration before surgery and the width of the tumour-free resection margin. In the last years, markers of systemic inflammatory response became more interesting in this context. In 1863, Virchow hypothesised that inflammatory process was a factor contributing to development and progression of neoplasms (7) . The body's physiological response to systemic inflammation, trauma, or stress in its wide sense, is lymphocytopenia and neutrophilia. It was demonstrated that the neutrophil to lymphocyte ratio (NLR) was a good marker of systemic immunologic response to stress. Under physiological circumstances, this ratio remains below 5, while in pathological conditions (severe infection, systemic inflammation) it is significantly higher.
Although at first this parameter was applied in the assessment of general condition of critically ill patients and in monitoring of SIRS (8) , its prognostic value in neoplasms has also been noticed. In systemic inflammatory response, serum concentration of positive acute phase proteins, including fibrinogen, is also increased. Changes in fibrinogen concentration in trauma (in its wide sense), significantly contributing to post-trauma coagulopathy, have been reported (9) . Correlation between hyperfibrinogenaemia and the results of treatment of gastrointestinal, genital, and lung tumours has been demonstrated.
Although colorectal cancer is one of the most common neoplasms, methods for management of patients with stage IV CRC remain controversial. This is due to the lack of uniform criteria for selection of the appropriate treatment method and for assessment of the results. There is also no consent as to unfavourable prognostic factors; moreover, specific publications concerning this problem contradict each other.
MATERIAL AND METHODS
The analysis included 130 consecutive patients (70 men and 60 women) who underwent surgical treatment at the Department of Oncological and Reconstructive Surgery, Memorial Institute and Cancer Center in Gliwice, due to colorectal cancer metastases to the liver in the years 2001-2009. The patients' age ranged from 33 to 82 years (median: 60 years).
In 70 cases (54%), the primary lesion was located in the colon (in 37 patients in the sigmoid), and in the remaining 60 cases (46%) -in the rectum. Of 60 patients with rectal cancer, 37 (62%) underwent radiotherapy. In 21 (35%) radiotherapy was pre-operative and in 16 (27%) -post-operative. Synchronous metastases were found in 50 (38%) and metachronous metastases -in 80 patients (62%). In patients with metachronous metastases, the time between colorectal surgery and the finding of metastases ranged from 2 to 65 months (mean: 18 months, median: 14 months). In 18 patients with synchronous metastases, the liver was operated on at the time of intestinal resection, while in 32 cases treatment of the liver was delayed for 1 to 11 months (mean: 4.7 months, median: 4 months). In 96 cases (74%) resection with radical intention was performed, while in 34 cases (26%), in which radical resection was not possible, radiofrequency ablation (RFA) was performed, alone (in 20 patients) or combined with resection (in 14 patients), depending on the location, size, and number of metastases.
Resection procedures included 37 right hepatectomies (of which 3 extended), 11 left hepatectomies (1 extended), 28 segmentectomies (1 or 2 segments), and 20 metastasectomies. After surgical resection, post-operative histopathological examination confirmed R0 resection in 78 patients (81%) and R1 resection in 18 (19%). In microscopically radical resections, a margin below 1 mm was achieved in 12 patients (15%); in 37 patients (47%) it was between 1 and 5 mm, and in 29 patients (37%) the margin exceeded 5 mm. In the whole group, the duration of the hospital stay ranged from 4 to 120 days (mean: 12.6 days, median: 10 days, standard deviation: 11.8), while in the "resection" group it was 5-120 days (mean: 13.5 days, median: 10.5 days, standard deviation: 12.8). In the "resection" group, 25 patients (26%) received adjuvant chemotherapy after liver resection. Twenty patients (80%) received 5-fluorouracin + leucovorin (5FU + LV) chemotherapy, while 5 patients (20%) were treated according to the FOLFOX regimen. In the whole group, the follow-up period ranged from 2 to 156 months. The mean follow-up period was 39.3 months. In the "resection" group, it ranged from 6 to 156 months (mean follow-up period: 44 months), while in patients who underwent thermoablation the follow-up period ranged from 2 to 67 months (mean follow-up period: 26 months). In this analysis, overall and disease-free survival (DFS) was evaluated in patients who underwent resection. In patients who received palliative treatment (RFA alone or combined with resection), only overall survival was assessed.
Survival was estimated using the KaplanMeier method. The effect of risk factors on overall and disease-free survival was analysed using univariate and multivariate Cox regression. Statistical calculations were performed using the R Foundation for Statistical Computing v. 2.14.0 (2011); http://www.r-project. org/.
RESULTS
In patients who underwent resection, 3-and 5-year overall survival rate was 64.5% and 46.6%, respectively. Median overall survival time in this group was 56 months. In patients who underwent RFA, 3-and 5-year overall survival rate was 33% and 9.5%, respectively. In comparison with the RFA group, in the resection group the 3-year survival rate was twice as high, and the 5-year survival rate -five times higher. These differences were statistically significant (p = 0.002). In the resection group, 3-and 5-year disease-free survival rate was 32% and 30.5%, respectively, with a median DFS time of 21 months. In the RFA group, DFS was not evaluated due to the lack of unequivocal criteria for cure and/or local relapse after such treatment.
In the resection group, in univariate analysis both positive resection margins and narrow margins (up to 1 mm) were found to be statistically significant unfavourable prognostic factor for DFS-free survival (p = 0.03 and p = 0.049, respectively; fig. 1 ). Unfavourable effect of positive resection margins on DFS-free survival in this group was also confirmed in multivariate analysis (p = 0.0018). Of the peripheral blood parameters analysed in the resection group, a significant effect on disease-free survival was found for fibrinogen concentrations over 400 mg/dl and the neutrophil to lymphocyte ratio over 5 ( fig. 2) , both in univariate (p = 0.0075 and 0.044, respectively) and multivariate analysis (p = 0.0042 and 0.03, respectively). In patients in whom the neutrophil to lymphocyte ratio exceeded 5 no cases of 5-year disease-free survival were observed. In univariate analysis, a significant effect on overall survival in the resection group was demonstrated for: the preoperative number of leukocytes (p = 0.0014) and neutrophils (p = 0.0036), and fibrinogen concentration (p = 0.029); however, in multivariate analysis only the number of leukocytes was a statistically significant factor (p = 0.0014). A prediction model for overall survival depending on fibrinogen concentration is presented in fig. 3 . Unfavourable effect on disease-free survival after liver resection was also demonstrated for: primary lymph node involvement (N+ vs. N-; p = 0.015) and grading (G) of the primary tumour (p = 0.018).
Diameter of the only or largest metastatic lesion had a significant effect on disease-free Fig. 3 . Prediction models for overall survival in the resection group depending on fibrinogen concentration or sex, location of the primary lesion, application of adjuvant chemotherapy after liver resection, time between surgical treatment of the primary lesion and the finding of metastases, and perioperative transfusion of red cell concentrate. Of peripheral blood parameters prior to liver resection, no effect on OS or DFS was demonstrated for the number of lymphocytes or preoperative CEA concentration. Statistically significant risk factors are presented in tab. 1 and 2. In the whole group, 4 patients (3%) died within 30 days after the procedure. All those patients underwent right hemihepatectomy. Two patients died due to liver failure, one due to extensive myocardial infarction, and one due to peritoneal haemorrhage. Post-operative complications are presented in tab. 3.
DISCUSSION
For many years numerous authors at hepatic surgery centres have been trying to determine unfavourable prognostic factors after resection of metastatic liver cancer. Generally accepted prognostic factors include: primary lymph node involvement, the number and size of metastases, and positive margins after resection of metastatic tumours. To this list some authors add preoperative CEA concentration, time to the finding of metastases, grading of the primary lesion, presence of metastases in two lobes, complications after liver resection, or markers of systemic inflammatory response. It should be noticed that in all analyses in which markers of inflammatory response were taken into account they turned out to be independent prognostic factors. A comparison of this study with an analysis of a smaller group of patients treated at our centre until 2007, in which no parameters of inflammatory response were evaluated, leads to similar conclusions (10).
Inflammatory reactions involve various components initiating and maintaining systemic response to the causative factor. Usually, inflammatory response is a self-limiting process with a favourable outcome; any disruption of this process may result in a pathology, including development of a neoplasm. Cancer cells themselves produce cytokines and chemokines affecting function of leukocytes and their migration to the tumour. The tumour's inflammatory component may contain various immunological cells, such as neutrophils, dendritic cells, macrophages, eosinophils, mastocytes, and lymphocytes (TIL -tumour infiltrating lymphocytes) (11). It was demonstrated that lymphocytic infiltrates surrounding liver metastases of colorectal cancer are a favourable prognostic factor after resection surgery; in addition, examination of lymphocytic infiltrates after liver resection demonstrated that vascular invasion by metastatic tumours is more common in patients with poor lymphocytic infiltration (12, 13) . Halazun and colleagues demonstrated that NLR > 5 prior to liver resec- Table 3 . Post-operative complications
Complication
Number of patientsall n (%)
Number of patients -"resection" group n (%)
Number of patients -"RFA" group n (%) Pneumonia 10 (7,7) 9 (9,4) 1 (2,9) Intestinal complications 6 (4,6) 5 (5,2) 1 (2,9) Prolonged biliary drainage 5 (3, ) tion due to metastases from CRC was associated with a statistically significantly shorter overall and disease-free survival time (14). Conclusions made by Neal and colleagues were similar (2). Our own results indicate a significant effect of inflammatory response markers on the prognosis after liver resection due to metastases from CRC. Preoperative neutrophil to lymphocyte ratio higher than 5 was an unfavourable prognostic factor for disease-free survival in both univariate and multivariate analysis; this is consistent with the results reported by both Halazun and Neal. However, in contrast with the results reported by those authors, no effect of NLR on overall survival was demonstrated. A significant effect on overall survival was observed for the number of neutrophils and leukocytes. The causes of hyperfibrinogenaemia in cancer patients are not completely understood. In some cases this may be due to its increased production in the liver as a part of systemic inflammatory response to a neoplasm; however, in a large group of patients with hyperfibrinogenaemia no signs of systemic inflammatory response can be found. Although hyperfibrinogenaemia is a confirmed unfavourable prognostic factor in treatment of the primary lesion in numerous neoplasms, including primary colorectal cancer (15-18), its predictive value after resection of metastases has not been analysed. Our results confirm a hypothesis that preoperative fibrinogen concentration is an independent prognostic factor after after liver resection due to metastases from CRC. The effect of resection margins on treatment outcome is still discussed. There is no doubt that liver resection due to metastases from CRC, a relapse in the remaining hepatic tissue may occur even in 50% of cases. An analysis of 244 patients treated by Cady and colleagues (1998) demonstrated that liver resection should be considered only in patients in whom a margin of at least 1 cm could be achieved (19). This is often impossible (only in 16-55% of hepatectomies) due to the location of metastatic lesions in the liver; therefore, a large proportion of patients was disqualified from resection based on this criterion. However, later studies performed at other centres verified this view. Using a combination of histopathological examination and genetic examination of the margins (KRas, p53), Kokudo and colleagues demonstrated that micrometastases in the margins are rare and located in close proximity to the main metastatic tumour. An acceptable resection margin was 2 mm (with a 6% risk of a relapse in the cut line) and resection with a smaller margin was also considered acceptable (20).
Dutch authors (de Haas and colleagues) analysed 436 patients, of whom 24% underwent R1 resection and the remaining patients -R0 resection, and demonstrated no significant effect of positive (R1) resection margins on overall or disease-free survival. Positive margins on histopathological examination correlated with the size of the largest tumour ≥3 cm, the presence of metastases in two lobes, and the necessity of intraoperative blood transfusion (21). In a multi-centre analysis of 557 patients, Pawlik and colleagues observed that relapse in the liver was significantly more common after R1 resection than after R0 resection, while in patients with a resection margin ≥1 mm the relapse rate was the same regardless of the width of the resection margin. A positive surgical margin was the only significant predictive factor for a relapse in the cut line, while for a relapse far from the cut line it was the presence of > 3 metastases (22). Figueras and colleagues also demonstrated no direct effect of free margin below 1 cm on the rate of relapse in the liver (23). In a retrospective analysis of 297 liver resections, Arru and colleagues found no negative effect of positive or free margins below 1 cm on overall survival. Disease-free survival or local relapse rate were not assessed in that study (24) . Bakalakos and colleagues analysed 238 liver resection and demonstrated unfavourable effect of positive resection margins on overall survival (25). Technical problems associated with assessment of resection margins in the liver and the fact that ultrasonic knives commonly used for liver resection evaporate ca. 1-2 mm of a potential resection margin should also be taken into account. An additional margin of ca. 1 mm may be achieved using argon coagulation. Taking these factors into account, it should be stated that impossibility of an R0 resection should not be considered a contraindication to surgery. This prevalent view has been confirmed by our results. In the analysed material, no effect of resection margins (positive vs. free) on overall survival was found, which is consistent with the results of de Haas and Arru. However, a significant unfavourable effect of positive or narrow free margins (below 1 mm) on disease-free survival was demonstrated. This is consistent with observations of Pawlik and colleagues.
CONCLUSIONS
Liver resection due to metastases from colorectal cancer is a safe treatment method with a perioperative mortality rate of 3% and a high 3-year overall and disease-free survival rate -over 30% and over 60%, respectively. An analysis of our own material confirmed the effect of certain widely accepted risk factors on survival and demonstrated the effect of systemic inflammatory response on the prognosis. In addition, a hypothesis of a significant effect of preoperative fibrinogen concentration on survival after liver resection due to CRC was confirmed.
Adjuvant chemotherapy after liver resection, (5FU +LV), applied in the analysed period, had no positive effect on treatment outcome.
